Gleolan, a dye used for brain imaging, can help surgeons visualize tumor tissue during surgery for glioblastoma multiforme. Malignant transformation occurs from aggregation of genetic alterations and ...

The glioblastoma multiforme market is expected to witness a significant positive shift owing to the positive outcomes of several products during the developmental stage by key players such as Avita ...

BPM31510 is a first-in-class therapeutic targeting tumor metabolism to re-program mitochondrial microenvironment in Warburg-avid tumorsBoth ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to WP1122 for the treatment of glioblastoma multiforme, according to a ...

Glioblastoma multiforme (GBM) remains one of the most aggressive adult brain tumours, with median survival rarely exceeding 15 months. Yet a subset of patients—often classified as long-term ...

Glioblastoma multiforme (GBM) remains the most aggressive primary brain tumour in adults, characterised by rapid proliferation, diffuse infiltration and resistance to conventional therapies. Current ...

BEIJING & BURLINGTON, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and ...

Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham demonstrated that 92% of evaluable patients treated with ...

Findings from a seven-year research project suggests that there could be a new approach to treating one of the most common and devasting forms of brain cancer in adults - Glioblastoma Multiforme (GBM) ...

Research led by doctors and scientists have identified a gene that may provide a therapeutic target for the deadly, treatment-resistant brain cancer glioblastoma multiforme (GBM). Research led by ...

Booking Health today announced the release of findings examining international patient access to personalized dendritic cell ...

Immunotherapy has revolutionized treatment for many forms of cancer, but glioblastoma multiforme (GBM), the most common and deadly form of brain cancer, has remained untouched. GBM tumors are ...